Heteronemin induces anti-Proliferation in cholangiocarcinoma cells via inhibiting TGF-β pathway

Hung Yun Lin, Shu Leei Tey, Yih Ho, Yung Tang Chin, Kuan Wang, Jacqueline Whang-Peng, Ya Jung Shih, Yi Ru Chen, Yung Ning Yang, Yu Cheng Chen, Yi Chang Liu, Heng Yuan Tang, Yu Chen SH Yang

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

A marine sesterterpenoid-type natural product, heteronemin, retains anticancer effects. In the current study, we investigate the antitumor mechanism of heteronemin in cholangiocarcinoma cells and further explore its molecular targets. Initially, heteronemin exhibited potent cytotoxic effects against cholangiocarcinoma HuccT1 and SSP-25 cells. In vitro, heteronemin altered the abilities of cell adhesion and cell migration in HuccT1 and SSP-25 cell lines. It repressed messenger ribonucleic acid (mRNA) expression levels of transforming growth factor (TGF)-β, mothers against decapentaplegic homolog (SMAD) and Myc,whose protein products play important roles in regulating cell growth, angiogenesis, and metastasis. In addition, heteronemin altered several signaling pathways. The results indicate that heteronemin was able to modulate cell adhesion, the expression of extracellular matrix (ECM) receptors, the TGF-β pathway, cell motility, the membrane integration, metastasis response, matrix metalloproteinase (MMP) remodeling, the regulation of metabolism, sprouting angiogenesis, transcription factors, and vasculogenesis in cholangiocarcinoma cell lines. The results also suggest that it activated multiple signal transduction pathways to induce an anti-proliferation effect and anti-metastasis in cholangiocarcinoma. In conclusion, heteronemin may be used as a potential medicine for anticancer therapy.

Original languageEnglish
Article number489
JournalMarine Drugs
Volume16
Issue number12
DOIs
Publication statusPublished - Dec 6 2018

Fingerprint

Cholangiocarcinoma
Transforming Growth Factors
Neoplasm Metastasis
Cell Adhesion
Cell Movement
Smad Proteins
Cell Line
Angiogenesis Inducing Agents
heteronemin
Biological Products
Matrix Metalloproteinases
Signal Transduction
Transcription Factors
Cell Membrane
Medicine
RNA
Growth

Keywords

  • Cholangiocarcinoma
  • Heteronemin
  • TGF-β pathway

ASJC Scopus subject areas

  • Drug Discovery

Cite this

Heteronemin induces anti-Proliferation in cholangiocarcinoma cells via inhibiting TGF-β pathway. / Lin, Hung Yun; Tey, Shu Leei; Ho, Yih; Chin, Yung Tang; Wang, Kuan; Whang-Peng, Jacqueline; Shih, Ya Jung; Chen, Yi Ru; Yang, Yung Ning; Chen, Yu Cheng; Liu, Yi Chang; Tang, Heng Yuan; Yang, Yu Chen SH.

In: Marine Drugs, Vol. 16, No. 12, 489, 06.12.2018.

Research output: Contribution to journalArticle

Lin, Hung Yun ; Tey, Shu Leei ; Ho, Yih ; Chin, Yung Tang ; Wang, Kuan ; Whang-Peng, Jacqueline ; Shih, Ya Jung ; Chen, Yi Ru ; Yang, Yung Ning ; Chen, Yu Cheng ; Liu, Yi Chang ; Tang, Heng Yuan ; Yang, Yu Chen SH. / Heteronemin induces anti-Proliferation in cholangiocarcinoma cells via inhibiting TGF-β pathway. In: Marine Drugs. 2018 ; Vol. 16, No. 12.
@article{697965f9b2d24153b45c4504e8a60384,
title = "Heteronemin induces anti-Proliferation in cholangiocarcinoma cells via inhibiting TGF-β pathway",
abstract = "A marine sesterterpenoid-type natural product, heteronemin, retains anticancer effects. In the current study, we investigate the antitumor mechanism of heteronemin in cholangiocarcinoma cells and further explore its molecular targets. Initially, heteronemin exhibited potent cytotoxic effects against cholangiocarcinoma HuccT1 and SSP-25 cells. In vitro, heteronemin altered the abilities of cell adhesion and cell migration in HuccT1 and SSP-25 cell lines. It repressed messenger ribonucleic acid (mRNA) expression levels of transforming growth factor (TGF)-β, mothers against decapentaplegic homolog (SMAD) and Myc,whose protein products play important roles in regulating cell growth, angiogenesis, and metastasis. In addition, heteronemin altered several signaling pathways. The results indicate that heteronemin was able to modulate cell adhesion, the expression of extracellular matrix (ECM) receptors, the TGF-β pathway, cell motility, the membrane integration, metastasis response, matrix metalloproteinase (MMP) remodeling, the regulation of metabolism, sprouting angiogenesis, transcription factors, and vasculogenesis in cholangiocarcinoma cell lines. The results also suggest that it activated multiple signal transduction pathways to induce an anti-proliferation effect and anti-metastasis in cholangiocarcinoma. In conclusion, heteronemin may be used as a potential medicine for anticancer therapy.",
keywords = "Cholangiocarcinoma, Heteronemin, TGF-β pathway",
author = "Lin, {Hung Yun} and Tey, {Shu Leei} and Yih Ho and Chin, {Yung Tang} and Kuan Wang and Jacqueline Whang-Peng and Shih, {Ya Jung} and Chen, {Yi Ru} and Yang, {Yung Ning} and Chen, {Yu Cheng} and Liu, {Yi Chang} and Tang, {Heng Yuan} and Yang, {Yu Chen SH}",
year = "2018",
month = "12",
day = "6",
doi = "10.3390/md16120489",
language = "English",
volume = "16",
journal = "Marine Drugs",
issn = "1660-3397",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "12",

}

TY - JOUR

T1 - Heteronemin induces anti-Proliferation in cholangiocarcinoma cells via inhibiting TGF-β pathway

AU - Lin, Hung Yun

AU - Tey, Shu Leei

AU - Ho, Yih

AU - Chin, Yung Tang

AU - Wang, Kuan

AU - Whang-Peng, Jacqueline

AU - Shih, Ya Jung

AU - Chen, Yi Ru

AU - Yang, Yung Ning

AU - Chen, Yu Cheng

AU - Liu, Yi Chang

AU - Tang, Heng Yuan

AU - Yang, Yu Chen SH

PY - 2018/12/6

Y1 - 2018/12/6

N2 - A marine sesterterpenoid-type natural product, heteronemin, retains anticancer effects. In the current study, we investigate the antitumor mechanism of heteronemin in cholangiocarcinoma cells and further explore its molecular targets. Initially, heteronemin exhibited potent cytotoxic effects against cholangiocarcinoma HuccT1 and SSP-25 cells. In vitro, heteronemin altered the abilities of cell adhesion and cell migration in HuccT1 and SSP-25 cell lines. It repressed messenger ribonucleic acid (mRNA) expression levels of transforming growth factor (TGF)-β, mothers against decapentaplegic homolog (SMAD) and Myc,whose protein products play important roles in regulating cell growth, angiogenesis, and metastasis. In addition, heteronemin altered several signaling pathways. The results indicate that heteronemin was able to modulate cell adhesion, the expression of extracellular matrix (ECM) receptors, the TGF-β pathway, cell motility, the membrane integration, metastasis response, matrix metalloproteinase (MMP) remodeling, the regulation of metabolism, sprouting angiogenesis, transcription factors, and vasculogenesis in cholangiocarcinoma cell lines. The results also suggest that it activated multiple signal transduction pathways to induce an anti-proliferation effect and anti-metastasis in cholangiocarcinoma. In conclusion, heteronemin may be used as a potential medicine for anticancer therapy.

AB - A marine sesterterpenoid-type natural product, heteronemin, retains anticancer effects. In the current study, we investigate the antitumor mechanism of heteronemin in cholangiocarcinoma cells and further explore its molecular targets. Initially, heteronemin exhibited potent cytotoxic effects against cholangiocarcinoma HuccT1 and SSP-25 cells. In vitro, heteronemin altered the abilities of cell adhesion and cell migration in HuccT1 and SSP-25 cell lines. It repressed messenger ribonucleic acid (mRNA) expression levels of transforming growth factor (TGF)-β, mothers against decapentaplegic homolog (SMAD) and Myc,whose protein products play important roles in regulating cell growth, angiogenesis, and metastasis. In addition, heteronemin altered several signaling pathways. The results indicate that heteronemin was able to modulate cell adhesion, the expression of extracellular matrix (ECM) receptors, the TGF-β pathway, cell motility, the membrane integration, metastasis response, matrix metalloproteinase (MMP) remodeling, the regulation of metabolism, sprouting angiogenesis, transcription factors, and vasculogenesis in cholangiocarcinoma cell lines. The results also suggest that it activated multiple signal transduction pathways to induce an anti-proliferation effect and anti-metastasis in cholangiocarcinoma. In conclusion, heteronemin may be used as a potential medicine for anticancer therapy.

KW - Cholangiocarcinoma

KW - Heteronemin

KW - TGF-β pathway

UR - http://www.scopus.com/inward/record.url?scp=85058448060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058448060&partnerID=8YFLogxK

U2 - 10.3390/md16120489

DO - 10.3390/md16120489

M3 - Article

C2 - 30563284

AN - SCOPUS:85058448060

VL - 16

JO - Marine Drugs

JF - Marine Drugs

SN - 1660-3397

IS - 12

M1 - 489

ER -